Half Year 2026 Ypsomed Holding AG Earnings Call Transcript
Key Points
- Ypsomed Holding AG (XSWX:YPSN) reported a strong 21% growth in its core Delivery Systems business, reaching CHF267 million in sales for the first half of the year.
- The company has successfully transformed into a focused self-injection specialist, completing several strategic divestitures to streamline operations.
- Ypsomed has launched innovative platforms such as YpsoDot, YpsoFlow, and YpsoLoop, which are recyclable and provide a competitive edge in the market.
- The company has a robust financial position with an EBIT margin of 32.4% in its core business and a strong operating cash flow, allowing it to finance growth CapEx effectively.
- Ypsomed is expanding its global footprint with new manufacturing sites in China, Germany, and the US, enhancing its capacity to meet future demand.
- The pen segment experienced flat sales, indicating potential challenges in this area despite new platform introductions.
- The company faces potential dis-synergies and stranded costs following the divestiture of its Diabetes Care business.
- Ypsomed's EBIT margin decreased from 36% to 32.4% due to ramp-up costs for new contracts and capacity expansions.
- The company anticipates a lower growth rate in the Delivery Systems segment for the fiscal year '26/'27 due to the phase-out of contract manufacturing.
- There is a risk of idle capacity costs as Ypsomed expands its manufacturing capabilities, which could impact profitability.
(audio in progress) conference call. Today, with CEO Simon Michel and CFO Samuel Kunzli, we'd like to go over our first half-year results. We'll go over the key achievements and the financial drivers for this first half-year. After a short presentation, we will open the floor to questions.
Thank you for joining us again, and a warm welcome to all. Without further ado, I'll pass on then to Simon. Please.
Thank you very much, Sam, for introduction. Good morning, everybody. Great to take the time for us here this morning. We have a great results. You have seen it this morning. Let us deepen it. I will do a channel overview and then hand over to Samuel for the financials.
And as you know me, I always start with our purpose. This is why we get up every morning. Ypsomed is making self-care simpler and easier. And those four are our structural growth drivers.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
